Clinical Trials Browser

Phase NA × Neoplasms × Doxorubicin × Clear all

NCT01490060 2016-04-11

Fosaprepitant in Patients Receiving Ifosfamide-based Regimen

Phase NA Completed

47 enrolled 6 charts

Nausea, Neoplasms, Sarcoma, Vomiting